Polymyalgia Rheumatica: all 138 studies
Page 1 of 2. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.
- Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia RheumaticaRecruitingNCT07749547Not applicable
- DNA Methylation in PMRNot yet recruitingNCT07748195
- Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia RheumaticaNot yet recruitingNCT07394478
- Sarilumab Efficacy and Safety in Adults With Early Polymyalgia RheumaticaRecruitingNCT07286214Phase 3
- Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumaticaRecruitingNCT07279688Phase 3
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and EfficacyRecruitingNCT07150000
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)Not yet recruitingNCT07132164
- Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia RheumaticaRecruitingNCT07010484
- A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.Not yet recruitingNCT06766552
- Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic DiseasesEnrolling by invitationNCT06763783Phase 4
- Performance of a Fast-track Pathway for Giant Cell Arteritis DiagnosisRecruitingNCT06742671
- AYLo - AutoimmunitY and Loss of yRecruitingNCT06696027
- A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor ImmunotherapyRecruitingNCT06647134
- Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)RecruitingNCT06609668
- Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia RheumaticaNot yet recruitingNCT06558357
- Visual Involvement in Giant Cell ArteritisRecruitingNCT06500728
- Assessing Biomarker in Giant Cell Arteritis and Polymyalgia RheumaticRecruitingNCT06460142
- Investigation of the Influence of the Human Microbiome on Giant Cell ArteritisRecruitingNCT06279065
- TocILizumab in aorTitis in GCA (TILT)RecruitingNCT06271018
- Clonal Hematopoiesis in Giant Cell ArteritisNot yet recruitingNCT06244069
- Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)RecruitingNCT06004154
- DANIsh VASculitis Database (DANIVAS)RecruitingNCT05935709
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT05904301
- Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell ArteritisRecruitingNCT05479448
- Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal InsufficiencyRecruitingNCT05435781Phase 4
- Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid TreatmentRecruitingNCT05193396Phase 4
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
- Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)RecruitingNCT04102930
- Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisTerminatedNCT05168475Phase 2Results posted
- A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154TerminatedNCT04972968Phase 2Results posted
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).CompletedNCT03923738Phase 1Results posted
- KPL-301 for Subjects With Giant Cell ArteritisCompletedNCT03827018Phase 2Results posted
- Tocilizumab Plus a Short Prednisone Taper for GCACompletedNCT03726749Phase 4Results posted
- Assessment of Giant Cell Arteritis Medical Practices in FranceCompletedNCT03658889Results posted
- Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia RheumaticaTerminatedNCT03600818Phase 3Results posted
- Evaluation of Efficacy and Safety of Sarilumab in Patients With GCATerminatedNCT03600805Phase 3Results posted
- Baricitinib in Relapsing Giant Cell ArteritisCompletedNCT03026504Phase 2Results posted
- Ustekinumab for the Treatment of Giant Cell ArteritisTerminatedNCT02955147Phase 1/2Results posted
- Validation of a Diagnostic Algorithm of Giant Cell ArteritisCompletedNCT02703922Not applicableResults posted
- Efficacy and Safety Study of Sirukumab in Patients With Giant Cell ArteritisTerminatedNCT02531633Phase 3Results posted
- An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)CompletedNCT01791153Phase 3Results posted
- Tocilizumab for Patients With Giant Cell ArteritisCompletedNCT01450137Phase 2Results posted
- Study of Tocilizumab to Treat Polymyalgia RheumaticaCompletedNCT01396317Phase 2Results posted
- A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia RheumaticaTerminatedNCT01364389Phase 2Results posted
- Timed Release Tablet Prednisone in Polymyalgia RheumaticaCompletedNCT00836810Phase 2/3Results posted
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's ArteritisCompletedNCT00556439Phase 2Results posted
- Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE)Active, not recruitingNCT07670546Phase 3
- Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Active, not recruitingNCT06331312Phase 3
- A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)TerminatedNCT06281236Phase 1
- Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia RheumaticaCompletedNCT06172361Phase 3
- Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMRCompletedNCT06130540Phase 1
- Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.CompletedNCT06011512
- Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)CompletedNCT05767034Phase 3
- Melanocortin Gene Expression in Lymphocytes of Polymyalgia PatientsCompletedNCT05681676
- Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)CompletedNCT05663333
- Treat-to-target Prednisolon Taper in Patients With Polymyalgia RheumaticaActive, not recruitingNCT05636501Not applicable
- Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell ArteritisActive, not recruitingNCT05623592Phase 2
- CXCR4-PET/CT for Diagnosing Giant Cell ArteritisCompletedNCT05604482Not applicable
- Validation of the PMR Activity Score and Evolution of Patient-reported Outcomes in Patients With Polymyalgia RheumaticaCompletedNCT05542316
- Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR RelapseActive, not recruitingNCT05533164Phase 3
- Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently DiagnosedCompletedNCT05533125Phase 3
- A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)CompletedNCT05436652Phase 2
- Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionCompletedNCT05380453Phase 3
- Polymyalgia Rheumatica Associated to Primary Sjogren SyndromeStatus unknownNCT05312944
- Giant Cell Arteritis - Optimization of DiagnosticsCompletedNCT05248906
- Pharmacogenetic Studies on Anti-IL-6 Receptor Monoclonal Antibodies on the Treatment of Rheumatic DiseasesStatus unknownNCT05045001
- Comparative Study of 3 Tocilizumab Products in Normal Healthy VolunteeersCompletedNCT04885829Phase 1
- Tofacitinib as a GC Sparing Agent for Polymyalgia RheumaticaCompletedNCT04799262Phase 2
- Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's BiopsiesCompletedNCT04727879Not applicable
- PRediction Of DIverse Glucocorticoids toxIcity OUtcomeSActive, not recruitingNCT04664465
- Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery BiopsyCompletedNCT04554290
- Improved Diagnostics and Monitoring of Polymyalgia RheumaticaActive, not recruitingNCT04519580
- Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in EuropeStatus unknownNCT04397237
- COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesTerminatedNCT04335747
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
- Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCAStatus unknownNCT04239196Phase 2
- Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease CourseCompletedNCT04204876
- Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell ArteritisCompletedNCT04204512
- Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease)CompletedNCT04142515
- PET Imaging of Giant Cell and Takayasu ArteritisActive, not recruitingNCT04071691
- Low-dose Interleukin-2 Treatment on Polymyalgia RheumaticaStatus unknownNCT04062006Phase 2
- TARGET GCAT RegistryTerminatedNCT04049071
- BAriCitinib Healing Effect in earLy pOlymyalgia RheumaticaCompletedNCT04027101Phase 2
- Pilot Study of the Impact of Giant Cell Arteritis and Its Treatment on the Autonomy of the Elderly in the First Year of CareTerminatedNCT03961113
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)CompletedNCT03812302Phase 2
- Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell ArteritisCompletedNCT03765424
- Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and TocilizumabCompletedNCT03745586Phase 1/2
- Ustekinumab for the Treatment of Relapse of Refractory Giant Cell ArteritisCompletedNCT03711448Phase 2
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
- Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORSCompletedNCT03632187Phase 3
- Treatment With Leflunomide in Patients With Polymyalgia RheumaticaStatus unknownNCT03576794Phase 3
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
- Diagnostic Accuracy of FDG PET/CT of Cranial Arteries in GCACompletedNCT03409913
- Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-DopplerCompletedNCT03360162
- Study of T Lymphocytes in Patients With Horton DiseaseStatus unknownNCT03313102Not applicable
- FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid TreatmentCompletedNCT03285945
- A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)CompletedNCT03263715Phase 3